Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report) posted its quarterly earnings results on Wednesday. Unicycive Therapeutics Stock PerformanceShares of UNCY stock traded up $0.43 during trading hours on Wednesday, reaching $5.43. Unicycive Therapeutics has a twelve month low of $3.71 and a twelve month high of $8.74. Unicycive Therapeutics Company Profile(Get Free Report)Unicycive Therapeutics, Inc, a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. See AlsoReceive News & Ratings for Unicycive Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unicycive Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.